Provided by Tiger Fintech (Singapore) Pte. Ltd.

10x Genomics, Inc.

14.30
+1.209.16%
Post-market: 14.490.1900+1.33%19:59 EDT
Volume:3.45M
Turnover:48.25M
Market Cap:1.78B
PE:-20.67
High:14.30
Open:13.16
Low:13.11
Close:13.10
52wk High:24.76
52wk Low:6.78
Shares:124.49M
Float Shares:112.38M
Volume Ratio:1.40
T/O Rate:3.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6917
EPS(LYR):-1.5162
ROE:-11.30%
ROA:-9.45%
PB:2.30
PE(LYR):-9.43

Loading ...

Nov 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 05, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Oct 30, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2024

Major Issues Report

Form 8-K - Current report
Oct 09, 2024

Major Issues Report

Form 8-K - Current report
Aug 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Jul 11, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Major Issues Report

Form 8-K - Current report
Jun 13, 2024

Major Issues Report

Form 8-K - Current report
May 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2024

Major Issues Report

Form 8-K - Current report